Vimarsana
Biggest News Aggregation in the World

Engagement Solution Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Engagement Solution Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Engagement Solution Center Today - Breaking & Trending Today

Publicis Health adds clinical trial muscle with purchase of BBK Worldwide - Vimarsana News

Publicis Health adds clinical trial muscle with purchase of BBK Worldwide

The deal gives Publicis Health access to BBK’s TrialCentralNet, a patient recruitment management system that streamlines study enrollment.

PUBLICIS HEALTH ACQUIRES BBK WORLDWIDE - Vimarsana News

PUBLICIS HEALTH ACQUIRES BBK WORLDWIDE

/PRNewswire/ -- Publicis Health, the health and wellness vertical of Publicis Groupe, today announced the acquisition of BBK Worldwide (BBK), a full-service...

PUBLICIS HEALTH ACQUIRES BBK WORLDWIDE - Vimarsana News

PUBLICIS HEALTH ACQUIRES BBK WORLDWIDE

/PRNewswire/ -- Publicis Health, the health and wellness vertical of Publicis Groupe, today announced the acquisition of BBK Worldwide (BBK), a full-service...

PUBLICIS HEALTH ACQUIRES BBK WORLDWIDE - Vimarsana News

PUBLICIS HEALTH ACQUIRES BBK WORLDWIDE

NEW YORK, Jan. 18, 2022 /PRNewswire/ -- Publicis Health, the health and wellness vertical of Publicis Groupe, today announced the acquisition of B...

BBK Worldwide launches patient-centric trial resource - Vimarsana News

BBK Worldwide launches patient-centric trial resource

BBK Worldwide launches patient-centric trial resource With the Engagement Solution Center, the patient-recruitment services specialist is aiming to improve the patient-centricity and inclusivity of studies. BBK Worldwide has announced the creation of its Engagement Solution Center, a new resource designed to centralize design, management, operations, and communications of various patient-visit support services. The center is geared toward easing the burden of research for rare and orphan diseases in addition to larger and Phase IV/V studies. Outsourcing-Pharma disc...